PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $259,597 | +9.0% | 6,383 | +29.8% | 0.00% | 0.0% |
| Q1 2023 | $238,131 | -5.5% | 4,916 | -7.8% | 0.00% | 0.0% |
| Q1 2021 | $252,000 | -34.7% | 5,332 | -15.7% | 0.00% | -50.0% |
| Q4 2020 | $386,000 | -48.2% | 6,327 | -60.3% | 0.00% | -33.3% |
| Q3 2020 | $745,000 | -25.1% | 15,935 | -18.7% | 0.00% | -40.0% |
| Q2 2020 | $995,000 | +19.0% | 19,602 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $836,000 | +195.4% | 18,730 | +217.6% | 0.01% | +400.0% |
| Q4 2019 | $283,000 | +10.1% | 5,897 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $257,000 | -15.2% | 5,703 | -35.4% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -32.1% | 8,823 | -7.1% | 0.00% | 0.0% |
| Q3 2018 | $446,000 | +94.8% | 9,493 | -17.2% | 0.00% | +100.0% |
| Q3 2017 | $229,000 | – | 11,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |